The pandemic saw a significant rise in number of cases of anxiety
Pakistan has lifted a rule barring the use of AstraZeneca's Covid-19 vaccine for people below the age of 40, in a bid to help inoculate people who need to travel for education or jobs abroad, particularly Saudi Arabia, a health official said.
Pakistan, which relies heavily on remittances from its expatriate workers in Saudi Arabia, has primarily used Chinese vaccines - Sinopharm, CanSinoBio and Sinovac - in its inoculation drive and, till now, only used AstraZeneca for those above 40.
The Saudi authorities have not approved the Chinese shots, so people with only those vaccinations still need to quarantine, which is unaffordable for many, Faisal Sultan, a health adviser to the prime minister, said.
"From today, we have lifted the restriction for use of AstraZeneca for below 40 years," Sultan told private news channel Geo television on Tuesday.
Saudi Arabia has approved four Covid-19 vaccines for arrivals wanting to avoid quarantine, namely AstraZeneca, Pfizer, Moderna and Johnson and Johnson.
Pakistan has received 1.2 million doses of AstraZeneca under the Covax facility.
Sultan said the government was using diplomatic channels to see if Saudi Arabia would approve Chinese vaccines in future.
As of June 11, 1.3 per cent of Pakistan's 220 million people had been fully vaccinated and 3.8 per cent had received at least one dose, mostly Sinopharm or Sinovac, official figures show.
The pandemic saw a significant rise in number of cases of anxiety
The art of glow... and glory
March being the World Endometriosis Awareness Month, we attempt to decode the not-so-widely understood condition that condemns its sufferers to a life of unbearable pain
UAE resident shares why she chose the 2020 Nissan Altima to be her road companion
Here are some landmarks that make the visit so much more worthwhile
Now calling a child or youngster “chubby” can be demeaning to them, for even an eight-year-old knows all about body-shaming
shashi tharoors world of words
When someone boasts he is “ahead of the curve”, in other words performing better, earlier or faster than the competition, that expression also has its roots in flying
The next twelve-month dividend yield is 5% with reference to IPO share price of Dh2.48 per share